Pharmaceuticals, Biotechnology and Life Sciences
OAKLAND, Calif.–(BUSINESS WIRE)–#biotechnology–OrthoTrophix, Inc. (www.orthotrophix.com), a privately-held biopharmaceutical company, announced today new results from a Phase 2 study of the osteoarthritis drug TPX-100.…
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–#INDstatus—PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for…
VIENNA, Va.–(BUSINESS WIRE)–CEL-SCI Corporation (NYSE American: CVM) is set to join the broad-market Russell 3000® Index at the conclusion of…
IRVINE, Calif.–(BUSINESS WIRE)–$NVUS #ISOM–Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders…
IRVINE, Calif.–(BUSINESS WIRE)–$NVUS #ISOM–Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders…
CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–AptarGroup, Inc. today announced that it has acquired two leading pharmaceutical services companies, Nanopharm Ltd. and Gateway…
CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–AptarGroup, Inc. today announced that it has acquired two leading pharmaceutical services companies, Nanopharm Ltd. and Gateway…
Medable to reduce dropout rate and improve patient retention in clinical trials with new telemedicine solution DIA 2019 Exhibit #2331…
MARLBOROUGH, Mass.–(BUSINESS WIRE)–The Advanced Math & Science Academy Charter School (AMSA) and Sunovion Pharmaceuticals Inc. (Sunovion) today announced completion of…
DUBLIN–(BUSINESS WIRE)–The “Cancer Immunotherapy Markets – Market Forecasts for Immuno-Oncology Therapeutics Including Executive and Consultant Guides and a Complete Listing…